Note 3 - Summary of Significant Accounting Policies - Schedule of Basic and Diluted Loss Per Share (Details) - shares			6 Months Ended
	Aug. 10, 2026	Jun. 30, 2026	Jun. 30, 2026	Jun. 30, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			4,178,976	68,972
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	2,115,154	6,445,438	2,115,154	0
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			1,995,000	0
Representative's Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			62,500	62,500
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			0	150
BP Peptides Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			6,322	6,322